N,N-BIS(2-CHLOROETHYL)-4-(6-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL)-1H-BENZIMIDAZOL-2-YL)ANILINE
UNII GEK7MWA74O
Substance Identification & Data
This profile provides standardized clinical and technical data for N,n-bis(2-chloroethyl)-4-(6-(6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl)-1h-benzimidazol-2-yl)aniline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GEK7MWA74O.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 166546-19-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H31Cl2N7 BGUPMWNOAXIUCI-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N,n-bis(2-chloroethyl)-4-(6-(6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl)-1h-benzimidazol-2-yl)aniline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.